Published on 14 December 2022
Description:
Join us in finishing off 2022 with IPT’s Winter edition! Read on for articles about Raman spectroscopy, cell and gene therapies, and the many ways in which digitalising the laboratory can help improve pharmaceutical research, development, and manufacturing.
22 articles from this collection:
IPT Winter 2022 Cover
ICON
ICON. Clear Focus. Better Outcomes.
IPT Winter 2022 - Contents
EDITORIAL DESK
As another year draws to a close, it’s the perfect time to reflect on the past while moving unwaveringly into the future.
Cell Phenotyping and Functional Measurements Using Flow Cytometry
IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading
Raman Analysers Take Centre Stage to Streamline Pharmaceutical Quality Control
How are handheld Raman devices and process analysers helping to streamline Quality Control (QC) procedures and enable continuous manufacturing?
Pharma Role
Five Factors Driving Cell and Gene Therapy Developers Towards Gammaretrovirus
What has led to the rising trend for Cell & Gene Therapy (CGT) developers to choose retroviral vectors over other potential vectors, and what are the many drivers behind this selection process?
Collaboration and Centralisation: The Key to Successful Drug Development
IPT talks to Dr Fiona McLaughlin and Neil Bell of Avacta Therapeutics about the need for cohesion when researching and developing a new drug between life science companies, academia, and medical practitioners
PM GROUP
The Pioneering Tech Speeding Up Drug Development
IPT talks to Johannes Stanta at Celerion about how improvements in molecular and cellular capabilities are aiding Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards
DEL, AI, and ML: The Digital Future of Research Tools
IPT talks to Noor Shaker at X-Chem about the adoption of AI and ML into life sciences and how pre-trained algorithms can aid research
Turning an Ocean of Data Into Actionable Wisdom To Support Optimal Site Identification
Advancements in AI can help the pharmaceutical industry identify the best sites for their clinical trials through the harnessing of Big Data
The Burden of Proof – Implementing Blockchain in Life Sciences
Blockchain technology is fast becoming a mainstay in pharma companies. What is the draw for these companies to use it, and how can it help improve data collection and protection in the future?
International Clinical Researcher of the Year 2023
International Clinical Researcher of the Year 2023 is now open for entry
Digitalisation – A Giant Step Towards Global Access to Medicine
How will the mass integration of digital technologies into the pharmaceutical industry benefit the most underserved countries?
Error Mitigation in Pharmaceutical Quality Assurance and Control
Ensuring pharma products are manufactured in a safe and controlled way is a priority. How can the industry ensure that this happens?
An Alternative Regulatory Pathway for Generic Orally Inhaled Drug Products
The in vitro-in silico ‘alternative’ bioequivalence pathway for generic inhaled drug products, and how to factor in patient variability to successfully replace your comparative clinical end-point study
Managing the Complex Regulatory Pathways for Bioprinting Breakthroughs
Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is complex, requiring developers to better understand the factors that impact regulatory classification
EVENTS
SAMEDAN
NATOLI
Natoli - Introducing the NCF-45 automatic encapsulation machine
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.